Skip to content

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02224677
Acronym
CLOCK
Enrollment
417
Registered
2014-08-25
Start date
2013-11-30
Completion date
2019-08-31
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniofacial Microsomia, Goldenhar Syndrome, Hemifacial Microsomia, Microtia, Oculo-Auriculo-Vertebral-Syndrome

Keywords

CFM, facial asymmetry, skin tag, facial tag, missing ear, small ear, anotia, microtia, epibulbar dermoid, coloboma, macrostomia, lateral cleft, infant, toddler, baby, neurodevelopment, cognition, socialization

Brief summary

This study is a multi-center, longitudinal cohort study of 125 infants with craniofacial microsomia (CFM) and 100 infants without craniofacial anomalies. Participants will undergo a series of evaluations between 0-3 years of age to comprehensively evaluate the developmental status of infants and toddlers with CFM. This research design will also explore specific pathways by which CFM may lead to certain outcomes. Specifically, the study explores (1) the longitudinal relations between facial asymmetry and emotion-related facial movements and socialization; and (2) associations among ear malformations, hearing and speech deficits and cognitive outcomes. Results of this research will ultimately lead to future investigations that assess new interventions and corresponding changes in current standards of care for children with CFM.

Interventions

None listed

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
Children's Hospital Los Angeles
CollaboratorOTHER
Children's Hospital of Philadelphia
CollaboratorOTHER
University of North Carolina
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
University of Illinois at Chicago
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
New York University
CollaboratorOTHER
Seattle Children's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

We are currently looking to enroll children with craniofacial microsomia through ClinicalTrials.gov Inclusion Criteria: Children with Craniofacial Microsomia: 1. Male or female infant participant is between 12 months and 24 months of age, or corrected age (for some infants born prior to their due date). 2. Infant participant has diagnosis of at least one of the following conditions: * Microtia * Anotia * Facial asymmetry AND Preauricular tag(s) * Facial asymmetry AND Facial tag(s) * Facial asymmetry AND Epibulbar dermoid * Facial asymmetry AND Macrostomia (i.e., lateral cleft) * Preauricular tag AND Epibulbar dermoid * Preauricular tag AND Macrostomia * Facial tag AND Epibulbar dermoid * Macrostomia AND Epibulbar dermoid 3. Infant participant has been diagnosed by a regional craniofacial team. 4. Legal guardian will provide written parental permission and informed consent prior to participation in study. 5. Legal guardian is willing to comply with all study procedures and be available for the duration of the study through Time 3. Parents of Children with Craniofacial Microsomia: * able to provide written consent for study participation, * willing to comply with all study procedures and * interested in participating in the entire study through Time 3.

Exclusion criteria

Children with Craniofacial Microsomia: 1. Subject is diagnosed with a known syndrome that involves microtia and/or underdevelopment of the jaw (Townes-Brocks, Treacher Collins, branchiootorenal, Nager, or Miller syndromes). 2. Subject has abnormal chromosome studies (karyotype) 3. Subject has a major medical or neurological condition that prevents participation in the study (e.g., cancer, cerebral palsy) at time of recruitment 4. Subject was born before 34 weeks estimated gestational age 5. Anything that would place the subject at increased risk or preclude the subject's full compliance with or completion of the study. 6. Sibling already participating in the CLOCK study 7. Subject's consenting parent does not speak English or Spanish Parents of Children with Craniofacial Microsomia 1. Anything that would preclude the subject's full compliance with or completion of the study. 2. Subject does not speak English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Neurodevelopmental Outcome MeasuresT1 study visit (12-14 months of age)BSID-III Cognitive Index
Phenotypic AssessmentsT1 study visit (12-14 months of age)2D photographs and video
Phenotypic Assessments Phenotypic Assessments Phenotypic AssessmentsT1 study visit (12-14 months of age)3D photographs,

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026